Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated to v3.6.5, indicating a newer version of the site template or content management update.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site revision has been updated to v3.6.4, indicating a deployment update. No study data or page content is affected by this change.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedFooter revision label updated from v3.6.2 to v3.6.3, indicating a minor site revision. This change reflects an update to the page's version tag rather than any alteration to the study content or details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page version. This does not alter trial data or visible content.SummaryDifference0.0%

- Check58 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that enrollment is closed. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label was standardized, with the revision notice updated to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor system update; the study details and user-facing content appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.